Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nikiforchin A, Gushchin V, King MC, et al. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. J Surg Oncol. 2021;123(4):1030–44.

    Article  Google Scholar 

  2. Ahmed S, Levine EA, Randle RW, et al. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(13):4226–31.

    Article  Google Scholar 

  3. Grotz TE, Mansfield PF, Royal RE, et al. Intrathoracic chemoperfusion decreases recurrences in patients with full-thickness diaphragm involvement with mucinous appendiceal adenocarcinoma. Ann Surg Oncol. 2016;23(9):2914–9.

    Article  Google Scholar 

  4. Sullivan BJ, Bekhor EY, Carpiniello M, et al. Diaphragmatic peritoneal stripping versus full-thickness resection in CRS/HIPEC: is there a difference? Ann Surg Oncol. 2020;27(1):250–8.

    Article  Google Scholar 

  5. Nikiforchin A, Gushchin V, Sittig M, et al. Outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy with and without diaphragmatic resection in patients with peritoneal metastases. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10669-9.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The Institute for Cancer Care, Mercy Medical Center, Baltimore, MD, USA

    Andrei Nikiforchin MD, Michelle Sittig RN, Vadim Gushchin MD, FACS & Armando Sardi MD, FACS

Authors
  1. Andrei Nikiforchin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Sittig RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vadim Gushchin MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Armando Sardi MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Armando Sardi MD, FACS.

Ethics declarations

Disclosures

The authors declare no conflicts of interest regarding the publication of this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nikiforchin, A., Sittig, M., Gushchin, V. et al. ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC. Ann Surg Oncol 29, 883–884 (2022). https://doi.org/10.1245/s10434-021-10824-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10824-2

Search

Navigation